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INTRODUCTION
Anaerobic bacteria can cause a variety of endogenous
infections [1]. Because of their persistent nature, they are
difficult to isolate from infection sites and are often
overlooked [2]. Moreover, anaerobes play a key role in
maintaining the balance between the host and its
colonizing organisms; anaerobic infections occur when
the harmonious relationship between the host and
bacteria has been disrupted. Mixed infections may arise in
the head and neck region (e.g., chronic sinusitis, chronic
otitis media, Ludwig’s angina, and periodontal abscesses)
[3]. Brain abscesses and subdural empyema are the most
common anaerobic infections of the central nervous
system [4,5]. Anaerobes are also responsible for pleu-
ropulmonary diseases, such as aspiration pneumonia,
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necrotizing pneumonia, lung abscess, and empyema [6].
In addition, these organisms play an important role in
various intra-abdominal infections, such as peritonitis and
intra-abdominal and liver abscesses. They are frequently
isolated in female genital tract infections, such as
salpingitis, pelvic peritonitis, tuboovarian abscess,
vulvovaginal abscess, septic abortion, and endometritis.
Anaerobic bacteria are also often found in bacteremia and
infections of the skin, soft tissues, and bones [1,2]. Their
isolation requires appropriate methods of collection,
transportation, and cultivation of specimens [7].
Treatment is complicated by their slow growth, polymi-
crobial nature, and growing resistance to antimicrobial
agents. Antimicrobial therapy is often the only form of
treatment required, or may be an important adjunct to a
surgical approach. Because anaerobes are generally
recovered in association with aerobic organisms, the
choice of antimicrobial agents should provide coverage for
both types of pathogens [8]. 
Despite a relatively low incidence, anaerobic infection
remains associated with significant mortality rates. Recent
estimates of case fatality rates in patients with clinically
significant anaerobic bacteremia range from 25% to 44%
[9]. The aims of this study were to determine the clinical
features of a broad range of obligate anaerobic organisms
isolated from, for example, blood, cerebrospinal fluid,
peritoneal fluid, and pleural fluid, and to define the factors
independently associated with mortality.  
METHODS
The study was conducted at Severance Hospital at
Yonsei University College of Medicine in Seoul, Korea,
from January 1996 to December 2003. The facility is a
1,544-bed, tertiary care referral center with hematopoietic
stem cell and solid organ transplant specialty services.
This study examined 1,050 consecutive adult patients (>17
years old), with 3,169 specimens from sterile fluid and
abscess cultures for anaerobic bacteria that were retro-
spectively identified from clinical microbiology records.
Following the first positive anaerobic culture, outcome
data were collected from the patients’ medical and clinical
microbiology laboratory records for 30 days, until dis-
charge or death. The data were based on mortality within
30 days following the first positive blood culture.
The primary endpoint was death, recorded as the
number of days after detection of the positive culture
results for anaerobic bacteria. The following variables
were assessed: personal information (i.e., age and sex),
dates of admission and discharge, mode of acquisition
(nosocomial or community-acquired), type of infection
(polymicrobial or monomicrobial), source of infection,
culture results, types of surgeries and procedures per-
formed during hospitalization, diagnosis at discharge, and
presence of concurrent underlying disease (e.g., heart,
liver, lung, or kidney disease, hypertension, diabetes,
malignancy, immunosuppression). The presence of an
underlying disease was based on the description made by
the physician. Each disease variable was similarly defined;
a patient was only considered to have a disease if it was
documented as ongoing at the time of the positive culture
results. Immunosuppression was said to be present if the
patient had a history of solid organ transplant, AIDS,
pregnancy, or was undergoing high-dose steroid therapy.
Specimens for anaerobic cultures were primarily biopsy
samples or needle aspirates; swabs made up only a minor
part of the specimens. All specimens were transported and
incubated in anaerobic systems. Colonies present on
blood agar media were evaluated through aerotolerance
tests, catalase tests, Gram staining, and susceptibility
tests. Sources of infection were determined by
radiological, surgical, or microbiological evidence of
barrier compromise or infectious pathology, such as
abscess or necrosis. The origin of bacteremia was also
defined by radiological, surgical, or microbiological
evidence. A case was designated bacteremia if no other
proven focus was discovered. 
In this study, no evidence of anaerobic infection was
detected in brain abscess specimens. Based on the
National Nosocomial Infection Surveillance System
(NNISS) guidelines, the infection was deemed to be noso-
comial if a positive culture was drawn more than 48 h
following admission to the hospital [10]. Appropriate
coverage was defined as culture-directed antibiotic
coverage given at adequate doses. Inappropriate coverage
was defined as non-culture-directed coverage at inad-
equate doses, but was deemed acceptable if it was non-
culture-directed (especially when cultures were negative)
but showed signs of clinical improvement.
The results were expressed as the mean±standard
deviation (SD), or as a proportion of the total number of
patients or isolates. For continuous variables, mean values
were compared using a two- sample t-test for independent
samples. Differences in proportions were compared using
a χ2 test. All tests of significance were two-tailed and α was
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set at 0.05. Mortality was evaluated using univariate and
multivariate Cox proportional hazard models. All sta-
tistical analyses were performed using the SPSS software
program (version 12.0; SPSS Inc., Chicago, IL, USA).
RESULTS
Study population and patient characteristics
In total, 3,169 anaerobic organisms from 1,050 patients
were reported. Patients with clinically significant anaer-
obic infections ranged in age from 18 to 88 years (median,
58.0 years; mean, 54.1±16.8 years), and 57.7% of the patients
were men. The most frequent underlying conditions
(diagnosed at admission) were malignancy in 343 patients
(32.7%), diabetes mellitus in 132 patients (12.6%), renal
disease in 123 patients (11.7%), and liver disease in 88
patients (8.4%). Other underlying diseases included renal
or ureter stones, skin fistula, Ebstein anomaly, deep vein
thrombosis, and plegia. One hundred and fifty-seven
(15.0%) patients who had undergone predisposing surgery
were identified, and their mode of acquisition was
regarded to be of nosocomial origin. In addition, more
than half (56%) of those surgeries were performed on the
abdomen. 
Clinical features
Information on the symptoms of anaerobic infection
was available for 1,008 (96%) of 1,050 cases. Overall, 320
(30.5%) of those with case-defined illnesses experienced
pain at the affected site, and 230 (21.9%) complained of
discharged pus from lesions. Ten (1.4%) patients
presented with shock. The mean duration of illness was
20.0±23.8 days. Various diagnoses were derived from
anaerobic infections (Table 1). 
Each of the 38 and 63 specimens from patients with
sinusitis and chronic suppurative otitis, respectively, were
obtained by operative procedures; some were treated with
antibiotics, having no anaerobic coverage. Consequently, a
complete resection of the infected source was sufficient to
cure, with no additional antimicrobials.
In addition, 80 consecutive adult cases of lung abscess
and empyema were treated. Seventy-three percent of these
patients had a history of prior antibiotic use. The most
commonly administered antibiotic was cefopera-
zone/sulbactam at 40% (n=32), followed by vancomycin.
Treatment of these infections included pleural space
drainage (in the presence of empyema) and antimicrobial
agents. 
Fifty-eight patients with intra-abdominal infection
(37.2%) died during treatment. Appropriate management
of mixed intra-abdominal infections requires the admin-
istration of antimicrobials that are effective against both
aerobic and anaerobic components of the infection, and as
well as surgical correction and drainage of pus. Combination
therapies including aminoglycoside, quinolone, or a third-
generation cephalosporin plus an anti-anaerobic agent,
such as clindamycin or metron-idazole, were used. Single-
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Table 1. Diagnosis derived from anaerobic infections (n=1,050)
Anatomical site Diagnosis Number (%)
Head and neck Sinusitis 38 (3.6)
Otitis media 63 (6.0)
Retropharyngeal abscess 14 (1.3)
Lung and thorax Lung abscess or empyema 80 (7.6)
Abdomen Intraabdominal infection* 156 (14.9)
Soft tissue and extremities Burn 4 (0.4)
DM foot 79 (7.5)
Necrotizing fasciitis 20 (1.9)
Septic arthritis 16 (1.5)
Pressure sore 123 (11.7)
Blood Bacteremia 284 (27.0)
Catheter-related CAPD peritonitis 13 (1.2)
V-P shunt infection 3 (0.3)
Surgical wound Surgical site infection 157 (15.0)
* Intraabdominal infection included liver abscess, gall bladder stone or biliary tract infection, bowel obstruction, periappendiceal
abscess, or intra-abdominal abscess.
CAPD, continuous ambulatory peritoneal dialysis; V-P, ventriculo-peritoneal.
agent therapy included the use of a carbapenem or
piperacillin-tazobactam. 
Twenty cases of necrotizing fasciitis were treated. The
paucity of cutaneous findings early in the course of this
disease makes diagnosis difficult; four patients were
diagnosed within a few hours of receiving acupuncture on
the buttocks. Twelve of 20 patients died from necrotizing
fasciitis, but only one of those who underwent debride-
ment died. 
Abscess of the buttocks and pressure sores comprised
123 cases; a few simple abscesses did not require anti-
biotics, and some cases resolved through simple aspi-
ration or drainage. The cases of otitis media reviewed here
did not require antibiotics, although some required
surgical intervention, such as aspiration or drainage.
Cultured anaerobes from intracerebral abscesses were not
observed.
Microbiological features
Polymicrobial anaerobic infections represented 80.3%
of all clinically significant cases. The mean number of
pathogens, including aerobes and anaerobes, was 3.7±1.0
(minimum 1, maximum 5), and the mean number of
anaerobic organisms was 1.0±0.3 in each specimen. The
most common pathogens by rank were Bacteroides fragilis,
which accounted for 41.8% of anaerobic infections,
Clostridium spp. (11.8%), Prevotella spp. (9.4%), and
Peptostreptococcus spp. (8.4%). Escherichia coli (17.5%),
Staphylococcus aureus (7.5%), and Klebsiella pneumoniae
(7.5%) were common concomitant aerobic organisms
(Table 2). 
The most common anaerobic pathogen in 38 sinusitis
patients was Propionibacterium, whereas the remaining
sinusitis patients showed Peptostreptococcus and
Bacteroides spp. Sixty-three cases involved chronic sup-
purative otitis media and the predominant anaerobes
recovered were Peptostreptococcus and Bacteroides spp.
Lung abscess and empyema comprised 80 consecutive
adult cases. The predominant anaerobes in these cases
were Bacteroides, Prevotella, Fusobacterium, and Pepto-
streptococcus spp. 
One hundred and fifty-six cases of intra-abdominal
infections and nosocomial infections were suspected in 82
patients (51.3%). The predominant aerobic and facultative
microbes were E. coli and Streptococcus spp. (including
Enterococcus spp.); the most frequently encountered anaer-
obes were of the B. fragilis group and Peptostreptococcus
and Clostridium spp.
Abscess of the buttocks and pressure sores were
detected in 123 cases. The common pathogens were B.
fragilis, Peptostreptococcus asaccharolyticus, and
Bacteroides thetaiotaomicron, in order of the frequency
of occurrence.
The only anaerobe in all four burn wounds was
Peptostreptococcus. Two hundred and eighty-four cases
involved bacteremia due to anaerobes, and the most
frequent site of origin was the gastrointestinal tract.
All isolated strains of B. fragilis were sensitive to
metronidazole, but the resistance rate was 43% to
clindamycin, 33% to cefotaxime, and 25% to piperacillin.
Mortality and prognostic factors
Overall, the crude mortality rate was 29.7% (312 of
1,050 cases). The mean and median times to death were
10.7 and 3.5 days, respectively (range, 0.4-37 days).
Twelve of 20 (60%) patients died from necrotizing
fasciitis, but only one of the patients who underwent
debridement subsequently died. Despite sufficient
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Table 2. Isolated Bacteria
Bacteria No. (%)
Anaerobes
Bacteroides fragilis 1,325 (41.8)
Clostridium species 374 (11.8)
Prevotella species 298 (9.4)
Peptostreptococcus species 266 (8.4)
Bacteroides species 247 (7.8)
Peptostreptococcus asaccharolyticus 193 (6.1)
Peptostreptococcus magnus 193 (6.1)
Propionibacterium acnes 171 (5.4)
Fusobacterium species 76 (2.4)
Bifidobacterium species 63 (2.0)
Clostridium perfringens 54 (1.7)
Total 3,260
Concomitantly isolated aerobes
Escherichia coli 1,325 (41.8)
Staphylococcus aureus 172 (7.5)
Klebsiella pneumoniae 172 (7.5)
Coagulase-negative staphylococci 144 (6.3)
Enterococcus faecalis 114 (5.0)
Streptococcus species 87 (3.8)
Proteus mirabilis 65 (2.8)
Pseudomonas aeruginosa 56 (2.4)
Enterobacter species 42 (1.8)
Proteus vulgaris 39 (1.7)
Serratia marcescens 38 (1.6)
Providencia species 22 (1.0)
Others 19 (0.8)
Total 2,295
therapy, half of the patients (50%) suffering from pressure
sores died. Fifty-eight patients (37.2%) died during the
treatment of intra-abdominal infections. No recorded
death was due to sinusitis or otitis media during the study
period. In patients with anaerobic bacteremia, adequate
surgical intervention resulted in a higher survival rate
than in cases without appropriate intervention procedures
(81.8% versus 57.1%, p<0.05). As expected, the incidence
of death was higher among those who received inap-
propriate antibiotic therapy (32.5%) compared to those
who received appropriate therapy (27.3%) as well as
acceptable antibiotic coverage.
Each variable was evaluated using a Cox proportional
hazard model to determine factors associated with
mortality. The four discrete factors were increasing age
per year over 18 years (p=0.011), inappropriate
prescription of antibiotics at diagnosis (p=0.014), no use
of postoperative antibiotics (p=0.019), and underlying
liver disease (p=0.0006). In particular, liver disease
(p=0.003) and old age (p=0.005) were significantly
associated with mortality during multivariate Cox pro-
portional hazard analysis (Table 3).
DISCUSSION
Neoplasms, hematologic disorders, organ transplant,
recent surgery, diabetes mellitus, and the use of cytotoxic
agents or corticosteroids are predisposing factors for
anaerobic infection [2]. This study also showed that
anaerobic infections often occurred in patients with
cancer when the balance between the host and bacteria
was disrupted.
In many patients, pain and pus discharge at the affected
site were the chief complaints, whereas few patients
presented with shock. Consistent with the findings of
Cheon et al. [11], the most common presenting symptom
in bacteremia patients was fever (70%).
The appropriate management of anaerobic infection
depends on suspicion and appropriate documentation of
the bacteria causing infection [12]. In this study,
inappropriate anaerobic antibiotics prescriptions at the
time of diagnosis (p=0.014) and the lack of postoperative
antibiotics (p=0.019) were associated with a poor
prognosis resulting in mortality. Regarding the use of
antibiotics, Hecht noted that antibiotic-resistant anaer-
obic bacteria have become increasingly recognized as a
confounding factor in the selection of therapeutic agents
[13]. Although appropriate therapy for anaerobic infec-
tions has been associated with significant reductions in
mortality, most clinical laboratories still do not perform
routine anaerobic susceptibility tests [14,15]. In a previous
8-yr study, resistance to antimicrobial agents, such as
piperacillin, cefotaxime, and clindamycin, was not
uncommon among 913 clinical isolates of B. fragilis group
organisms, and antimicrobial susceptibility testing was
deemed necessary before using one of these drugs [16].
Thus, concentrating on an appropriate narrow-spectrum
of antibiotics is important. 
Procedures such as abscess drainage, necrotic tissue
debridement, and closed-space infection decompression
are important adjuncts to a medical approach [12].
However, this study did not find a correlation between
surgical intervention and mortality. 
Shin et al. [17] reported that B. fragilis and Pepto-
streptococcus magnus were most frequently isolated in
anaerobic bacterial infections. However, in this study, the
most common pathogens were B. fragilis (41.8%)
followed by Clostridium spp. The most common con-
comitant aerobic isolate was E. coli, which is why a
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Table 3. Prognostic factors associated with mortality
Univariate analysis (p) Multivariate analysis (p) Odds ratio
Age 0.011 0.005 2.6
Sex 0.4
Inappropriate antibiotic treatment at diagnosis 0.014 0.45 1.9








relationship between the development of intestinal tract
cancer and intra-abdominal infection was postulated,
although the results reported here were not statistically
significant.
This study, which examined patients with infections due
to a broad range of anaerobic pathogens, found that age
and liver disease were strong, independent risk factors for
mortality in multivariate analysis. Crude rather than
attributable mortality was reported because the relative
contribution of anaerobic infections to the overall mor-
tality rate could not be reliably ascertained. The data
demonstrate a 29.7% crude mortality rate for clinically
significant anaerobic infections. The majority of previous
studies on patients with anaerobic infections, which
included a broad range of anaerobic pathogens, also
reported mortality as crude mortality rates and published
estimates ranging from 25% to 44% [9,18]. In several cases,
mortality was assessed with reference to discharge from
the hospital, or the interval of antibiotic treatment [18]. 
The present study provides a recent perspective on the
clinical significance of infections due to a broad range of
anaerobic species. When combined with careful clinical
assessment, this information may be helpful in deter-
mining the clinical significance of cultures with anaerobic
organisms. The strength of this study is the diversity of the
study population and the relatively large sample size
examined. 
The present study, however, has certain limitations.
First, as with any retrospective review, potential for selec-
tion bias and data omission exists. Second, not all
analyzed variables were necessarily included in the
present study; thus, both liver disease and the severity of
illness should be included as independent variables in
future studies to confirm their association with mortality.
Despite these limitations, strong and independent
associations were demonstrated among age, underlying
liver disease, and mortality. 
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